A phase 2 study of Velcade [bortezomib] in subjects with relapsed or refractory follicular B-cell lymphoma.
Phase of Trial: Phase II
Latest Information Update: 25 Dec 2012
At a glance
- Drugs Bortezomib (Primary)
- Indications Follicular lymphoma
- Focus Therapeutic Use
- 02 Nov 2010 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 09 Feb 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.
- 09 Feb 2009 Additional lead trial centre and lead investigator identified as reported by ClinicalTrials.gov, last updated 9 Feb 2009.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History